Last updated: April 25, 2026
What is TRAVATAN Z and what product does it map to?
TRAVATAN Z is the brand name for travoprost ophthalmic solution (used for elevated intraocular pressure, including glaucoma and ocular hypertension). The commercial product is typically supplied as a sterile ophthalmic solution in a multiple-dose bottle with a topical dosing schedule.
Which companies supply the product (brand and channel)?
TRAVATAN Z is marketed by Alcon in most major markets. Distribution into pharmacies and wholesalers is handled through Alcon’s commercial channel partners in each country.
Market-facing entities:
- Brand/marketing authorization holder (typical): Alcon
- Commercial distribution: Alcon distribution network and contracted wholesalers/retail pharmacy channels
What are the core input categories suppliers provide for TRAVATAN Z?
TRAVATAN Z requires suppliers for multiple input streams that are standard for sterile ophthalmic products:
| Input stream |
Typical supplier role |
What it affects |
| Active pharmaceutical ingredient (API) |
API manufacturer |
Drug substance cost, impurity profile, regulatory consistency |
| Sterile manufacturing |
Contract manufacturing organization (CMO) or in-house site |
Sterility assurance, batch release |
| Primary packaging |
Bottle, dropper components, labels |
Container integrity, dosing accuracy |
| Secondary packaging |
Cartons, inserts |
Distribution compliance and patient labeling |
| Regulatory/quality systems |
QMS, validation, testing labs (often integrated) |
Release testing and documentation |
How does the supplier picture typically split for ophthalmic travoprost products?
For travoprost brands, the supplier stack usually separates into:
1) API supply (travoprost drug substance)
2) Drug product manufacturing (sterile ophthalmic solution fill-finish)
3) Packaging supply (bottle and dispensing system components)
4) Brand distribution (pharmacy wholesaling under the brand owner)
Who supplies TRAVATAN Z API and drug product?
No verifiable, complete supplier list (API manufacturer(s), specific fill-finish site(s), and packaging component suppliers) can be produced from the information provided.
Key Takeaways
- TRAVATAN Z is travoprost ophthalmic solution, marketed through Alcon’s commercial channel in typical markets.
- Supplier coverage for TRAVATAN Z must be decomposed into API, sterile drug product manufacturing, packaging, and distribution.
- A complete, named supplier list requires product-specific regulatory and labeling dossier data that is not included in the prompt.
FAQs
1) Is TRAVATAN Z manufactured by the same company that markets it?
Often the brand owner markets and distributes the product, while API and fill-finish may come from specialized manufacturing partners, depending on the market and supply contract.
2) Who supplies travoprost for TRAVATAN Z?
Travoprost is supplied by an API manufacturer, which can vary by site and country. Named entities require product dossier or labeling disclosure.
3) What supplier types matter most for sterile ophthalmic products?
API suppliers, sterile fill-finish CMOs (or in-house sites), and primary packaging suppliers for container-closure integrity.
4) Do packaging suppliers differ from drug manufacturers?
Yes. Bottle and dispensing system components typically come from packaging suppliers specialized in ophthalmic container-closure systems.
5) How can I identify the exact manufacturing site behind TRAVATAN Z?
In practice this is determined through regulatory labeling/manufacturer-of-record details for each market, not from the brand name alone.
References
[1] FDA. “Drug Approval Package: TRAVATAN Z (travoprost ophthalmic solution).” U.S. Food and Drug Administration.
